Vascular occlusion devices
The vascular occlusion device with a braided structure and optimized bending stiffness ratios addresses entanglement and delivery challenges, ensuring efficient and trauma-free deployment and retention within aneurysms, enhancing procedural simplicity and device performance.
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- STRYKER CORP
- Filing Date
- 2026-03-11
- Publication Date
- 2026-06-30
Smart Images
Figure 2026108693000001_ABST
Abstract
Description
Technical Field
[0001] The present disclosure generally relates to medical devices and endovascular medical procedures, and more particularly to devices and methods for occluding vascular disorders such as aneurysms.
Background Art
[0002] Vascular occlusion devices or implants are used for various reasons, such as the treatment of endovascular aneurysms. An aneurysm is an expansion of a blood vessel such as a blood vessel, which may pose a risk to the patient's health due to rupture, coagulation or dissociation. For example, if an aneurysm in a patient's brain ruptures, it can cause a stroke, leading to brain damage and death. Brain aneurysms are detected in patients, for example, after seizures or bleeding, and may be treated by applying a vascular occlusion device.
[0003] Generally used vascular occlusion devices include soft, helically wound coils formed by winding platinum (or platinum alloy) wire strands around a "primary" mandrel. This coil is then wound around a larger "secondary" mandrel and heat treated to impart a secondary shape. For example, U.S. Patent No. 4,994,069 issued to Ritchart et al. (which is hereby incorporated by reference in its entirety as if fully set forth herein) describes a vascular occlusion device that assumes a linear, helical primary shape when stretched for placement through the lumen of a delivery catheter and a folded, complex secondary shape when released from the delivery catheter and placed in the vasculature. A complex three-dimensional secondary shape can be imparted to the vascular occlusion device to more appropriately frame and fill an aneurysm, and the stiffness / flexibility of the vascular occlusion device can be changed.
[0004] To deliver a vascular occlusion device to a desired site within the vascular system, such as the aneurysm sac, it is commonly known that a small-profile delivery catheter or "microcatheter" is first positioned at that site using a guidewire. Generally, the distal end of the microcatheter is provided with a selected pre-formed bend, such as 45°, 26°, "J"-shaped, "S"-shaped, or other bends, depending on the patient's specific anatomical structure, by the attending physician or manufacturer, so that when the guidewire is withdrawn, it remains in the desired position for releasing one or more vascular occlusion devices into the aneurysm sac. Subsequently, the delivery assembly or "pusher" assembly or "wire" is passed through the microcatheter until the vascular occlusion device, coupled to the distal end of the delivery assembly, extends from the distal end opening of the microcatheter into the aneurysm sac. Once inside the aneurysm sac, a portion of the vascular occlusion device may be deformed or bent to allow for more efficient and complete filling. The vascular occlusion device is then released or "separated" from the distal end of the delivery assembly, and the delivery assembly is withdrawn through the microcatheter. Depending on the patient's specific needs, one or more additional vascular occlusion devices can be pushed through a microcatheter and released into the same aneurysm sac.
[0005] Importantly, fluoroscopy is typically used to visualize the occlusion device during delivery into the aneurysm, while magnetic resonance imaging (MRI) is typically used to visualize the treated site post-procedure (e.g., several weeks after initial treatment of the aneurysm) to confirm that the aneurysm sac is properly occluded. For this reason, it is important that the occlusion device is constructed to allow its radiopaqueness during aneurysm treatment while minimizing artifacts that interfere with visualization during post-procedure MRI (i.e., MRI-compatible). It is also important that such occlusion devices are "soft" (i.e., laterally flexible or adaptable) and thus non-traumatic to prevent rupture of the delicate tissue of the aneurysm.
[0006] Furthermore, it is crucial that such vascular occlusion devices remain within the aneurysm for an extended period. However, aneurysms with a large opening, commonly known as "platystrokera aneurysms," are difficult to position and retain vascular occlusion devices within the aneurysm sac. In particular, small, relatively thin vascular occlusion coils, no matter how skillfully they are positioned, lack sufficient mechanical strength to maintain their position within such aneurysm sacs. Therefore, to reliably place the vascular occlusion coil within the aneurysm sac, it is necessary to deploy stents or balloons in vessels adjacent to the aneurysm neck region, thereby complicating the procedure. To address this problem, vascular occlusion devices composed of at least partially braided (or woven) structures have been developed. Such braided vascular occlusion devices cover a larger neck and provide a more effective backbone across the aneurysm neck, allowing them to be effectively retained within platystrokera aneurysms without the need to deploy auxiliary aneurysm retention devices such as balloons or stents.
[0007] Vascular occlusion devices having a braided portion may also include coils at the distal and / or proximal ends to provide a non-traumatic end to the occlusion device in order to prevent damage to the aneurysm and the fragile tissue of the entire vascular system as the device advances during use. However, it has been found that the coil may become lodged in openings between the strands / wires of the braid, resulting in undesirable interaction with the braid and consequently entanglement between the braided portion of the occlusion device and the coil. This entanglement is also referred to herein as “engagement” or “biting.” When engagement occurs between the coil and the braid, it becomes impossible to properly operate the occlusion device, for example, preventing the device from being pulled back into a delivery device (e.g., a delivery catheter) and / or preventing proper transition of the occlusion device from the delivery configuration to the deployed expansion configuration. Entanglement between the coil and the braid occurs more frequently when deploying smaller sized occlusion devices into smaller aneurysm lumens. This is because the limited space within the smaller aneurysm constrains the device and increases contact between the coil segment and the braid.
[0008] Furthermore, regardless of whether coiled or braided occlusive devices are used, conventional occlusive device delivery systems require such devices to be relatively short and have limited expandability; otherwise, pushing them into and / or removing them from the microcatheter is difficult (if not impossible). Unfortunately, such small (short) occlusive devices are less desirable because their delivery into the aneurysm sac may require longer and more complex procedures. For example, a 7mm diameter neuroaneurysm sac is typically filled with 5-7 individual spring coils, which can make the procedure longer and more complex than reducing the number of devices.
[0009] Theoretically, the length of the occlusive device can be increased to reduce the number of occlusive devices required to treat an aneurysm. However, increasing the length of the occlusive device inevitably increases friction between such a device and the lumen of the delivery catheter. Therefore, in order to reliably deliver the occlusive device into the aneurysm, it is necessary to increase the column strength of such a occlusive device (for example, by selecting a material with a high Young's modulus or by increasing the diameter of the wire forming the occlusive device) and / or increase the diameter of the delivery catheter. However, as mentioned above, in order to access the aneurysm through a very narrow vascular system, it is important to make the diameter of the delivery catheter as small as possible and to make the occlusive device soft enough so as not to traumatize the delicate tissue of the aneurysm.
[0010] There are very few materials that enable relatively long vascular occlusion devices to have the necessary columnar strength to be delivered through relatively small-diameter delivery catheters, while simultaneously satisfying other counter-requirements, including the requirements for flexibility, radiopaqueness, and MRI compatibility. For example, known materials with relatively high Young's modulus and relatively high radiopaqueness, such as platinum-tungsten (PtW) alloys commonly used in the manufacture of vascular occlusion coils, could be used to provide the necessary columnar strength for relatively long vascular occlusion devices. However, to satisfy the flexibility requirement while allowing the vascular occlusion device to fit within a small-diameter delivery catheter, the diameter of the wire used to manufacture such vascular occlusion devices must be reduced. As a result, the radiopaqueness and columnar strength of the vascular occlusion device decrease, requiring the vascular occlusion device to be shortened and / or the diameter of the delivery catheter to be increased.
[0011] Therefore, there remains a need to provide a vascular occlusion device that minimizes the problem of entanglement between the coil and braided sections and satisfies the aforementioned requirements. [Overview of the project]
[0012] According to one embodiment of the medical devices and intravascular medical procedures of the present disclosure, a vascular occlusion device includes an elongated vascular occlusion device (e.g., at least 5 cm in length) configured to be implanted in an aneurysm sac. The vascular occlusion device has a delivery configuration when constrained within a delivery catheter and a deployment configuration when released from the delivery catheter into the aneurysm sac. The vascular occlusion device includes an elongated braided portion, which constitutes the main physical structure of the device. The braided portion is constructed by braiding together a plurality of elongated strands such that gaps or openings exist between the strands. The braided portion has a proximal end and a distal end. The braided portion has a first bending stiffness, which is a function of the material, shape, and dimensions of the braid.
[0013] Furthermore, the vascular occlusion device also has a distal coil segment coupled to the distal end of the braided portion. In another embodiment, the distal coil segment is usually much shorter than the braided portion and is used to provide a non-traumatic end to the device to avoid damage to the delicate tissues of the aneurysm and vascular structure during use of the device. The distal coil segment extends distally from the distal end of the braided portion to extend the overall length of the device. The distal coil segment has a second bending stiffness.
[0014] In another embodiment, the ratio of the second bending stiffness (bending stiffness of the distal coil segment) to the first bending stiffness (bending stiffness of the braided portion) is in the range of 0.5 to 1.0, or alternatively, 0.6 to 0.8. This range of ratio is determined to provide improved performance compared to conventionally available vascular occlusion devices having a braided portion and a distal coil segment. This distal coil segment to braided portion bending stiffness ratio results in an unexpected combination of desirable performance characteristics while also reducing the likelihood of engagement between the distal coil segment and the braided portion. For example, outside this range, the distal coil segment may be too stiff or too soft, increasing the likelihood of engagement and / or resulting in undesirable performance characteristics such as a lack of uniformity in loop distribution, more difficult deployment (e.g., requiring more manual manipulation by the clinician), and / or rebound force of the catheter that leads to loss of access to the aneurysm.
[0015] Alternatively, the ratio of the second bending stiffness (bending stiffness of the distal coil segment) to the first bending stiffness (bending stiffness of the braided portion) can be within the range of 0.5 to 1.0, or 0.55 to 0.9, or 0.65 to 0.75, or any suitable small range of 0.6 to 0.8, for example, 0.68 to 0.72.
[0016] In yet another embodiment, the vascular occlusion device may further include a proximal coil segment coupled to the proximal end of the braided portion. The proximal coil segment extends proximal from the proximal end of the braided portion to extend the overall length of the device. Like the distal coil segment, the proximal coil segment may be much shorter than the braided portion and provides the device with a non-traumatic end so as not to damage the delicate tissues of the aneurysm and vascular structure during use of the device. In yet another embodiment, the proximal coil segment may have substantially the same bending stiffness as the second bending stiffness.
[0017] In yet another embodiment, the braided portion of the vascular occlusion device may have a delivery configuration when confined within a delivery catheter and an unfolded configuration when released from a different delivery catheter. For example, the unfolded configuration may be an expanded shape having a larger cross-sectional dimension than the confined delivery configuration. For example, the delivery configuration may be substantially linear or a helical coil. The braided portion may be formed from a self-forming / expanding material biased to form the unfolded configuration when released from the delivery catheter. The braided portion may include shape-memory materials or components that self-form upon release or form the unfolded configuration when exposed to preset conditions such as temperature changes or electric currents. The unfolded configuration may be any suitable shape, such as one or more helical coils, one or more loops, or a complex three-dimensional shape. In another embodiment, the unfolded configuration is a three-dimensional shape having a cross-sectional dimension at least three times, or at least twice, or at least 1.5 times the cross-sectional dimension of the delivery configuration.
[0018] According to another aspect of the medical devices and intravascular medical procedures of the present disclosure, another vascular occlusion device comprises an elongated main portion having a proximal and distal end, and a plurality of openings along the longitudinal direction of the main portion. For example, the main portion may be a braid, mesh, a tube with a plurality of openings, or other suitable elongated structure. The tube may be an elongated hollow object, including, but not limited to, a flat sheet wound around a tube. The openings are large enough for the distal end of a non-traumatic distal segment to enter the opening and engage with the main portion. The vascular occlusion device has a delivery configuration when confined within a delivery catheter and a deployment configuration when released from the delivery catheter into an aneurysm sac. The main portion has a first bending stiffness.
[0019] The vascular occlusion device has a non-traumatic distal segment coupled to the distal end of the main portion. The distal segment extends distally from the distal end of the main portion. The distal segment has a second bending stiffness. The distal segment has a distal tip, and the opening is large enough for the distal tip to enter the opening and engage with the main portion.
[0020] The ratio of the second bending stiffness (bending stiffness of the non-traumatic distal segment) to the first bending stiffness (bending stiffness of the main portion) is within the range of 0.5 to 1.0, or 0.6 to 0.8. This range of ratio is determined to provide improved performance compared to conventionally available vascular occlusion devices having a main portion and a non-traumatic distal segment, similar to the vascular occlusion devices described above. This distal segment to main portion bending stiffness ratio reduces the likelihood of engagement between the distal coil segment and the main portion, while also preventing unexpected combinations of desired performance. Outside this range, the distal segment may be too stiff or too soft, increasing the likelihood of engagement and / or resulting in undesirable performance characteristics.
[0021] Alternatively, the ratio of the second bending stiffness (bending stiffness of the distal segment) to the first bending stiffness (bending stiffness of the main part) may be in the range of 0.5 to 1.0, or in the range of 0.55 to 0.9, or in the range of 0.65 to 0.75, or in any suitable small range of 0.6 to 0.8, for example, in the range of 0.68 to 0.72.
[0022] In another embodiment, the distal segment may be a coil, a helical coil, a tube and a flexible rod, or a combination thereof. The distal segment may have a rounded and / or soft tip to provide a non-traumatic tip for the vascular occlusion device to avoid damaging the delicate tissues of the aneurysm and vascular structure during use of the vascular occlusion device.
[0023] In another embodiment, the vascular occlusion device may also have a non-traumatic proximal segment coupled to the proximal end of the main portion and extending proximal from the proximal end of the main portion. The proximal portion may have one or more of the same or similar characteristics as the distal segment.
[0024] In additional embodiments, any of the occlusive devices disclosed herein may be part of an occlusive system including an occlusive assembly and a delivery assembly. For example, an occlusive assembly may include any of the occlusive devices described herein and a pusher member detachably coupled to the occlusive device. The pusher member is configured to allow a clinician to advance the occlusive device along a delivery catheter through the patient's vascular system to a target site, such as an aneurysm, to be treated with the occlusive device, and to push the occlusive device out from the distal end of the delivery catheter to deploy the occlusive device.
[0025] In yet another embodiment, the vascular occlusion assembly may also include a separation device that detachably connects a pusher member to the vascular occlusion device. For example, the separation device may include electrolytic separation, mechanical connectors, thermal separation, dissolution separation, etc. The delivery assembly may include a delivery catheter into which the vascular occlusion device can be introduced in its compact delivery configuration. The delivery assembly may also include a guidewire for guiding the delivery catheter to a target implantation site in the patient's vascular system, such as an aneurysm. The guidewire is then removed, and the vascular occlusion device is advanced through the delivery catheter to the target implantation site.
[0026] In yet another aspect of this disclosure, the device may be any medical device having other features of the vascular occlusion device disclosed herein, but including an elongated main portion and a distal segment attached to the distal end of the main portion. For example, the medical device may be any suitable thrombectomy device, stent retriever, embolic filter, stent delivery system, other implantable device, guidewire, intravascular device, or other medical device. The medical device comprises an elongated main portion having a proximal and distal end, and a plurality of openings along the longitudinal direction of the main portion. For example, the main portion may be a braid, mesh, tube with a plurality of openings, or other suitable elongated structure. The tube may be an elongated hollow object, including, but not limited to, a flat sheet wound around a tube. The openings are large enough for the distal end of a non-traumatic distal segment to enter the opening and engage with the main portion. Optionally, the medical device may have a delivery configuration when confined within a delivery catheter and a deployment configuration when released from the delivery catheter into an aneurysm sac. The main part has a first bending rigidity.
[0027] The medical device has a non-invasive distal segment coupled to the distal end of the braided portion. The distal segment extends distally from the distal end of the main portion. The distal segment has a second bending stiffness. The distal segment has a distal tip, and the opening is large enough for the distal tip to enter the opening and engage with the main portion.
[0028] The ratio of the second bending stiffness (the bending stiffness of the non-invasive distal segment) to the first bending stiffness (the bending stiffness of the main portion) is within the range of 0.5 or more and 1.0 or less, or within the range of 0.6 or more and 0.8 or less. This range of ratios provides better performance than conventionally available medical devices having a main portion and a non-invasive distal segment. This bending stiffness ratio of the distal segment to the main portion results in an unexpected combination of desirable performance while also reducing the likelihood of engagement between the distal coil segment and the main portion. Outside this range, the distal segment may be too rigid or too flexible, increasing the likelihood of engagement and / or resulting in undesirable performance characteristics.
[0029] Alternatively, the ratio of the second bending stiffness (the bending stiffness of the distal segment) to the first bending stiffness (the bending stiffness of the main portion) may be within the range of 0.5 to 1.0, or within the range of 0.55 to 0.9, or within the range of 0.65 or more and 0.75 or less, or within any suitable small range of 0.6 or more and 0.8 or less, for example, within the range of 0.68 or more and 0.72 or less.
[0030] In another aspect, the distal segment may be a coil, a helical coil, a tube, and a flexible rod, or a combination thereof. The distal segment can have a rounded and / or soft tip to provide a non-invasive tip for a vascular occlusion device that avoids damaging the delicate tissues of aneurysms and vascular structures during use of the vascular occlusion device.
[0031] Methods for deploying any of the vascular occlusion devices and other medical devices disclosed herein into an anatomical cavity such as an aneurysm are also disclosed. In one method, the vascular occlusion device is inserted into a delivery catheter device in a compact delivery configuration and advanced through this delivery catheter device. The delivery catheter is first inserted into the patient's vascular system and advanced within the vascular system to position the distal end of the delivery catheter at a target insertion site. In this example, the target insertion site is an aneurysm. It should be understood that the target insertion site can be any suitable anatomical site within the vascular system where the vascular occlusion device is deployed. If a guidewire is used, the guidewire is first inserted into the patient's vascular system and advanced through this vascular system to the site of the aneurysm. The delivery catheter is then advanced along the guidewire to the aneurysm, after which the guidewire is removed.
[0032] Subsequently, the occlusive device is inserted into the delivery catheter in its compact delivery form and advanced along the catheter until its distal end is positioned at the target insertion site. The occlusive device is then pushed distally out of the delivery catheter using a pusher member. The distal segment (e.g., the distal coil segment) is advanced through the neck of the aneurysm into the aneurysm sac. As the occlusive device continues to advance out of the delivery catheter via the pusher member, the braided portion also advances into the aneurysm sac. Furthermore, once the occlusive device is released from the delivery catheter, it expands into its expanded configuration within the aneurysm sac. Once the entire occlusive device is inserted into the aneurysm sac, it can be detached from the pusher member, for example, by activating or activating a separation device. In some cases, a single occlusive device is sufficient to fill and occlude the aneurysm. If multiple occlusive devices are required, this process can be repeated to deliver a sufficient number of occlusive devices to fill and occlude the aneurysm.
[0033] Other and further embodiments and features of the disclosed invention will become apparent from the following detailed description with reference to the accompanying drawings. [Brief explanation of the drawing]
[0034] The drawings illustrate the design and usefulness of various embodiments of the devices and methods disclosed herein, with similar elements denoted by common reference numerals. Note that the drawings are not drawn to scale, and elements of similar structure or function are indicated by the same reference numerals throughout the drawings. Also note that the drawings are intended solely to facilitate the explanation of various embodiments of the disclosed technology. They are not intended to be an exhaustive description of the technology or a limitation of its scope, and the scope of the technology is defined solely by the appended claims and their equivalents. Furthermore, exemplary embodiments of the disclosed technology do not necessarily have all embodiments or advantages disclosed or described herein. Embodiments or advantages described in relation to a particular embodiment of the disclosed technology are not necessarily limited to that embodiment and may be implemented in any other embodiment, even if not so illustrated. To better understand how the above and other advantages and objectives of the technology are obtained, a more specific description of the technology, as briefly described above, will be provided by referring to the specific examples illustrated in the appended drawings. With understanding that these drawings and corresponding descriptions only illustrate exemplary embodiments of the disclosed technology and should not be considered to limit its scope, the technology will be described and presented in more specific and detailed terms through the use of the accompanying drawings.
[0035] [Figure 1] Figure 1 is a perspective view of a vascular occlusion device showing the distal coil segment engaged with the braided portion of the vascular occlusion device. [Figure 2] Figure 2A is a cross-sectional side view of a vascular occlusion system having a vascular occlusion device in a delivery configuration constrained within a delivery catheter. Figure 2B is a cross-sectional side view of the vascular occlusion system of Figure 1, with the vascular occlusion device deployed outside the delivery catheter in its expanded deployment configuration. [Figure 3]Figure 3 is a graph showing the relationship between the flexural stiffness ratio of the distal segment and main portion of the vascular occlusion device in Figure 1, and the performance characteristics and engagement problems for various ranges of flexural stiffness ratio. [Figure 4] Figure 4 is a graph of empirical data for embodiments of vascular occlusion devices constructed according to the designs in Figures 2A and 2B, showing the relationship between the bending stiffness ratio of the distal segment and main portion of the vascular occlusion device in Figure 1 and the performance characteristics and engagement problems for various ranges of bending stiffness ratio. [Figure 5] Figure 5 is a table of empirical data relating to examples of vascular occlusion devices with various bending stiffness ratios, constructed according to the designs in Figures 2A and 2B. [Figure 6] Figure 6 is a cross-sectional side view showing a guidewire being advanced into a portion of the patient's vascular system to the location of the aneurysm. [Figure 7] Figure 7 is a cross-sectional side view showing the guidewire and the patient's vascular system as the delivery catheter is advanced along the guidewire, as shown in Figure 6. [Figure 8] Figure 8 is a cross-sectional side view showing the vascular occlusion system from Figures 2A and 2B advancing within the delivery catheter from Figure 7 in order to deploy the vascular occlusion device into the aneurysm. [Figure 9] Figure 9 is a cross-sectional side view showing the vascular occlusion system from Figure 7 with the vascular occlusion device deployed inside the aneurysm. [Figure 10] Figure 10 is a flowchart illustrating an exemplary method for deploying a vascular occlusion device into an aneurysm using the vascular occlusion systems shown in Figures 2A and 2B. [Modes for carrying out the invention]
[0036] Figure 1 illustrates the engagement problem of a vascular occlusion device 100 including a braided portion 102 and a distal coil segment 104. The vascular occlusion device 100 comprises a main braided portion 102 and a distal coil segment 104 attached to the distal end 106 of the braided portion 102. During insertion of such a vascular occlusion device 100, which includes the braided portion 102 or other portions having an opening large enough to receive the distal coil segment 104, it has been found that the distal coil segment 104 can engage with the braided portion 102 as the vascular occlusion device transitions from a delivery configuration within the delivery catheter to an expanded deployment configuration as the vascular occlusion device 100 moves out of the delivery catheter and advances into an anatomical cavity such as an aneurysm. This engagement is shown in Figure 1, which shows the vascular occlusion device 100 in its expanded configuration having a three-dimensional shape. The distal coil segment 104 is inserted through the opening in the braided strands of the braided portion 102, as shown in Figure 1, and as a result, the distal coil segment 104 is firmly engaged with the braided portion. This engagement is a highly undesirable outcome because it prevents the vascular occlusion device 100 from being properly operated, for example, by preventing the device 100 from being pulled back into the delivery device (e.g., delivery catheter) and / or by preventing the vascular occlusion device 100 from properly transitioning from its delivery configuration to its deployed extended configuration.
[0037] This specification describes engagement issues and specific examples relating to vascular occlusion devices for occluding anatomical spaces (such as aneurysms), but the disclosure is not limited to such devices and covers any medical device comprising an elongated main portion and a distal segment attached to the distal end of the main portion. For example, the medical device may be any suitable thrombectomy device, stent retriever, embolic filter, stent delivery system, other implantable device, guidewire, intravascular device, or other medical device.
[0038] Referring to Figures 2A and 2B, a vascular occlusion system 200 is shown, which has a vascular occlusion device 210 that mitigates engagement problems. The vascular occlusion device 210 also exhibits good performance characteristics during insertion and use. The vascular occlusion system 200 comprises a delivery assembly 202 and a vascular occlusion assembly 204. As shown in Figures 6 and 7, the delivery assembly 202 may include a delivery catheter 206 and an optional guidewire 208. The vascular occlusion assembly 204 comprises the vascular occlusion device 210 and a pusher member 212 that is detachably coupled to the vascular occlusion device 210 via a separation device or joint 214. Figure 2A shows the vascular occlusion assembly 204 after the vascular occlusion device has been slidably positioned within the delivery catheter 206 so that it is in its compact delivery configuration.
[0039] The delivery catheter 206 is typically an elongated flexible tube, which may be, for example, a microcatheter. The delivery catheter 206 comprises an elongated sheath body 215 having a proximal portion 216, a distal portion 218, and a lumen 220 extending from the proximal portion 216 to the distal portion 218. The proximal portion 216 of the delivery catheter 206 is typically left outside the patient's body when the vascular occlusion system 200 is used and accessible to the clinician, while the distal portion 218 is sized and dimensional to reach a remote location in the patient's vascular system and is configured to deliver the vascular occlusion device 210 to an aneurysm. The delivery catheter 206 may also have one or more ports 222 that communicate with the lumen 220 for introducing fluid into or removing fluid from the sheath body 215. The sheath body 215 may be constructed from suitable polymer materials, metals and / or alloys, such as polyethylene, stainless steel, or other suitable biocompatible materials or combinations thereof. In some cases, the proximal portion 216 may include a reinforcing layer, such as a braided or coiled layer, to improve the ease of inserting the sheath body 215. The sheath body 215 may include a transition region between the proximal portion 216 and the distal portion 218.
[0040] The vascular occlusion device 210 comprises an elongated main portion 224 having a proximal end 226 and a distal end 228. The main portion 224 may be a braided portion comprising several strands woven together to form an elastic tubular member. Alternatively, the main portion 224 may include a mesh, or a tube having multiple openings (the tube may be any elongated hollow object, including, but not limited to, a flat sheet wound around a tube), or other elongated structures having multiple openings along the length of the main portion 224, e.g., along substantially the entire length of the main portion 224, or at least 50% of the length of the main portion 224, or at least 75% of the length of the main portion. The main portion 224 has a first bending stiffness, which is a measure of the main portion 224's resistance to bending deformation. This is typically expressed as bending moment per unit width, such as in units of "mN / mm". In the case of the braided portion 224, the first bending stiffness is determined by the braiding configuration and its secondary diameter (i.e., the outer diameter of the braided portion 224 or the outer diameter of the device 210).
[0041] Furthermore, the vascular occlusion device 210 has a flexible, non-traumatic distal segment 230 coupled to the distal end 228 of the main portion 224. The distal segment 230 has a proximal end 232 and a distal end 234. The distal segment 230 in the figure comprises a helical coil such that the distal segment 230 becomes a distal coil segment 230. The proximal end 232 of the distal coil segment 230 can be attached to the distal end 228 of the main portion 224 by any suitable means such as welding, mechanical fasteners, or adhesives. The distal segment 230 may also have a non-traumatic tip 236 attached to the distal end 234 of the helical coil 230. The non-traumatic distal segment 230 has a second bending stiffness lower than the first bending stiffness of the main portion 224. The distal segment 230 is more flexible than the main portion 224, i.e., has a lower bending stiffness than the first bending stiffness of the main portion, thereby providing a non-traumatic distal tip for the vascular occlusion device 210 that does not damage, rupture, or otherwise cause trauma to the delicate tissue of the aneurysm and / or vascular structure as the vascular occlusion device 210 exits the delivery catheter 206 and advances into the patient's vascular structure and aneurysm. Alternatively, the distal segment 230 may be any other suitable flexible structure that provides the desired non-traumatic properties, such as a polymer rod or tube.
[0042] The non-traumatic distal segment 230 has a second bending stiffness that is different from the first bending stiffness of the main portion 224. In the case of the distal coil segment 230, the second bending stiffness is a function of the diameter, pitch, primary coil diameter, and secondary coil diameter (secondary coil shape diameter) of the coil wire. As described herein, a specific range of the ratio of the second bending stiffness of the distal segment 230 to the first bending stiffness of the main portion 224 (hereinafter referred to as the “bending stiffness ratio”) can mitigate engagement problems while providing desirable performance characteristics of the vascular occlusion device 210. The second bending stiffness of the distal coil segment 230 can be manipulated with respect to a given first bending stiffness of the main portion 224 by controlling the configuration of the distal segment 230 along with the outer diameter of the distal segment 230 to target a desired range of the ratio of the second bending stiffness to the first bending stiffness.
[0043] The vascular occlusion device 210 is sized to be implanted in an aneurysm sac 240 (see Figures 6-9) and can have any shape or geometric form in its cross-section. For example, in the embodiments shown in Figures 1 and 2, the vascular occlusion device 210 takes the form of an elastic braided mesh or porous main portion 224 having a tubular shape that can be partially flattened by internal and / or external forces, and a distal segment 230 that is a helical coil.
[0044] Optionally, the vascular occlusion device 210 can have a compact delivery configuration when radially constrained within the delivery catheter 206, and can be configured to form a deployed configuration having a different secondary shape from the delivery configuration when released from the delivery catheter 206, such as for discharge into an aneurysm sac 240 or other anatomical lumen. Figure 2A shows the vascular occlusion device 210 in a compact delivery configuration that is held within the delivery catheter 206 and substantially conforms to the longitudinal path (i.e., shape) of the delivery catheter 206. For example, in Figure 2A, the vascular occlusion device 210 has a substantially linear axial shape. As shown in Figure 8, when inserted into the delivery catheter 206, the vascular occlusion device 210 follows the longitudinal path of the delivery catheter 206 within the vessel 242. When discharged from the delivery catheter 206, as shown in Figures 2B and 9, the vascular occlusion device 210 forms a deployed configuration that is a three-dimensional shape containing multiple loops and / or curves, which either do not overlap, overlap, or are a combination thereof. The cross-sectional dimensions of the vascular occlusion device 210 in its deployed configuration may be, for example, greater than 1.5 times, preferably greater than 2 times, and most preferably greater than 3 times, the cross-sectional dimensions of the vascular occlusion device 210 in its compact delivery configuration.
[0045] The deployed configuration of the vascular occlusion device 210 can be formed or programmed into the device by any suitable method. For example, the main portion 224 (e.g., a braided main portion 224) can be formed from a shape memory material. The main portion 224, such as the braided 224, can be formed from any suitable material, including, but not limited to, platinum alloys, platinum-tungsten alloys, gold alloys, or nitinol, or any combination thereof. The main portion 224 is wound around a mandrel in the shape of loops and / or curves of the deployed configuration, and then heat-treated to form or program the deployed configuration into the main portion 224. Alternatively, the main portion 224 can be formed from a shape memory material and programmed to become the deployed configuration when the main portion 224 is exposed to a preset condition such as a temperature change, electric current, or other shaping conditions.
[0046] As described herein, the main portion 224 can be formed by a braid having a desired length (e.g., over 5 cm, 5 cm to 45 cm, 5 cm to 30 cm, etc.). The braid can be formed from multiple wires or strands using a braiding machine and braided around a mandrel (e.g., a mandrel having a circular, elliptical, flat, or other shape depending on the desired final cross-sectional shape of the main portion 224). After braiding, the main portion 224 can be heat-set into its delivery configuration to form the linear "primary shape" of the mesh portion 224. The heat-set braid can then be wrapped around a second mandrel (e.g., a three-dimensional mandrel) and heat-set a second time to impart a three-dimensional unfolded configuration.
[0047] Referring to Figure 3, the graph shows the optimized combination of desired performance characteristics and minimized engagement for various ranges of bending stiffness ratios of the vascular occlusion device 210. The graph in Figure 3 plots the bending stiffness ratio against the outer diameter of the main portion 224 (device outer diameter or outer diameter of the secondary shape of the braided portion). The performance characteristics of the vascular occlusion device 210 include observable functional attributes such as uniformity of loop distribution within the aneurysm, ease of deployment, effective placement of the distal segment 230 within the aneurysm (i.e., the distal segment 230 remains within the aneurysm and does not advance outside the aneurysm during deployment), and the rebound force of the catheter during deployment (i.e., the magnitude of the reaction force acting on the delivery catheter 206 that causes displacement of the distal end 218 of the delivery catheter 206).
[0048] The graph in Figure 3 shows that when the bending stiffness ratio exceeds 1.0, the degree of engagement of the vascular occlusion device 210 increases, and the distal segment becomes too stiff, resulting in undesirable performance, such as a lack of uniformity in loop distribution within the aneurysm, difficulty in deployment requiring more user input (e.g., manipulation) to deploy the vascular occlusion device 210, inconsistent placement of the distal segment 230, and / or catheter rebound that causes the distal end 218 of the delivery catheter 206 to move away from the target insertion site.
[0049] Referring further to Figure 3, for a bending stiffness ratio in the range of 0.8 to 1.0, the vascular occlusion device 210 tends to resolve engagement problems but still exhibits undesirable performance characteristics. More specifically, the vascular occlusion device 210 with a bending stiffness ratio in the range of 0.8 to 1.0 results in a lack of uniformity in loop distribution, difficulty in deployment, requiring more user input (e.g., manipulation) to deploy the vascular occlusion device 210, and / or catheter rebound, which causes the distal end 218 of the delivery catheter 206 to move away from the target insertion site.
[0050] Figure 3 shows that a flexural stiffness ratio of the vascular occlusion device 210 in the range of 0.6 to 0.8 provides the best combination of desirable performance characteristics and engagement avoidance. A flexural stiffness in the range of 0.6 to 0.8 provides a vascular occlusion device 210 that results in a uniform loop distribution, ease of deployment requiring minimal user input during deployment, consistent placement of the distal segment 230 without detachment from the aneurysm, and minimal rebound that allows the distal end 218 of the delivery catheter 206 to remain properly positioned at the target insertion site, such as within the neck of the aneurysm.
[0051] As shown in Figure 3, when the vascular occlusion device 210 has a bending stiffness ratio of less than 0.6, the vascular occlusion device 210 exhibits excessive engagement during deployment, but also shows other desirable performance characteristics such as good uniformity of loop distribution, ease of deployment, consistent placement, and minimal catheter rebound. However, due to excessive engagement, a vascular occlusion device 210 with a bending stiffness ratio of less than 0.6 is undesirable.
[0052] Figures 4 and 5 provide empirical experimental data for several examples of prototypes of the vascular occlusion device 210 constructed according to the device 210 described herein, shown in Figures 1 and 2. The experimental data were used to analyze the effect of the bending stiffness ratio on engagement problems and performance characteristics and to determine the optimal bending stiffness range. The various prototypes are indicated as P1 to P6 in the graph in Figure 4 and Table 1 in Figure 5. The bending stiffness ratio of prototype P1 is 1.20. Tests were conducted on 15 simulated use cycles and 10 samples of each prototype design. As shown in Figures 4 and 5, prototype P1 exhibited undesirable performance characteristics and a high engagement rate (40%) for bending stiffness ratios greater than 1.0, as described herein.
[0053] Prototype P2 had a bending stiffness ratio of 0.95 and, as described herein for bending stiffness ratios in the range of 0.8 to 1.0, showed no engagement problems but exhibited undesirable performance characteristics. Prototype P3 had a bending stiffness ratio of 0.70, prototype P5 had a bending stiffness ratio of 0.71, and prototype P6 had a bending stiffness ratio of 0.67. Prototypes P3, P5, and P6 showed excellent performance characteristics and no engagement problems for bending stiffness ratios in the range of 0.6 to 0.8, as described herein. Furthermore, prototypes P3 (diameter OD3mm of vascular occlusion device 210), P5 (diameter OD6mm of vascular occlusion device 210), and P6 (diameter OD8mm of vascular occlusion device 210) demonstrate that differences in the diameter of the vascular occlusion device 210 do not significantly affect performance characteristics and / or engagement problems.
[0054] While prototype P4 exhibited excellent performance characteristics with a bending stiffness ratio of 0.55, prototype P4 also showed moderate engagement problems in which the distal segment 230 engaged with the main portion 224 during 20% of the simulated use cycles, as described herein for bending stiffness ratios of less than 0.60.
[0055] Alternatively, the bending stiffness ratio may be within the range of 0.55 to 0.9, or within the range of 0.65 to 0.75, or within any suitable smaller range of 0.6 to 0.8, for example, within the range of 0.68 to 0.72.
[0056] Returning to Figures 2A and 2B, the vascular occlusion assembly 204 also includes a pusher member 212. The pusher member 212 is located within the lumen 220 of the delivery catheter 206. The pusher member 212 has a proximal portion 250, which typically extends proximal to the proximal portion 216 of the delivery catheter 206, and a distal portion 252 that is detachably coupled to the proximal portion 226 of the vascular occlusion device 210 via a separation device 214. The pusher member 212 may be a coil, wire, tendon, conventional guidewire, torque-transmitting cable tube, hypotube, etc., having sufficient columnar strength to allow the vascular occlusion device 210 to be pushed into the aneurysm sac 240 through the distal end 218 of the delivery catheter 206 (see Figures 8 and 9).
[0057] The separation device 214 provides a detachable connection between the pusher member 212 and the vascular occlusion device 210. The separation device 214 may include electrolytic separation, mechanical connectors, thermally operated separation, dissolution separation, or other mechanical, thermal, and fluid pressure mechanisms. For example, the separation device 214 may be an electrolytically decomposable segment for electrolytically separating the vascular occlusion device 210 from the pusher member 212.
[0058] As shown in Figures 6 and 7, the optional guidewire 208 of the delivery assembly 202 has a proximal end 244 and a distal end 246. As shown in Figure 7, after the guidewire 208 is positioned within the patient's vascular system 242 with its distal end 246 positioned at the target insertion site, the delivery catheter 206 is advanced over the guidewire 208 with the guidewire 208 positioned within the lumen 220 of the delivery catheter 206. In a “rapid exchange” configuration of the delivery catheter 206 and guidewire 208, the guidewire 208 extends only through the distal portion of the delivery catheter 206, such as the rapid exchange lumen. The guidewire 208 is typically used by first advancing the guidewire 208 through the patient's vascular system to the target insertion site (e.g., the neck of an aneurysm filled by the vascular occlusion device 210), and then advancing the delivery catheter 206 over the guidewire 208 to the target insertion site.
[0059] Next, with reference to Figures 6–10, an exemplary method 300 for deploying a vascular occlusion device 210 into an anatomical body cavity using a vascular occlusion system 200 is described. This method is described in relation to deploying the vascular occlusion device 210 into an aneurysm sac 240 as an example. However, method 300 is not limited to deploying the vascular occlusion device 210 into an aneurysm sac 240, and the vascular occlusion device 210, or any other medical device disclosed herein, can be used to deploy into any suitable anatomical body cavity accessible via the patient's vascular system. As shown in the flowchart of Figure 10, step 302 involves inserting a guidewire 208 into the patient's vascular system 242 and advancing it to the target insertion site, i.e., the aneurysm sac 240. As described herein, the use of the guidewire 208 is optional and not required in method 300 for deploying a vascular occlusion device 210 using a vascular occlusion system 200.
[0060] In step 304, the delivery catheter 206 of the delivery assembly 202 is advanced along the guidewire 208 until its open distal end 218 is adjacent to or inside the aneurysm neck 248 of the aneurysm, as shown in Figure 7. In step 306, the guidewire 208 is withdrawn from the delivery catheter 206, leaving the delivery catheter 206 in place. In step 308, the vascular occlusion assembly 204 is inserted into the delivery catheter 206 of the delivery assembly 202 and advanced within the delivery catheter 206, positioning the distal end 234 of the vascular occlusion device 210 adjacent to the distal portion 218 of the delivery catheter 206. In this position, the proximal portion 250 of the pusher member 212 remains proximal to and lateral to the proximal portion 216 of the delivery catheter 206. In one embodiment of this method 300, before inserting the vascular occlusion device 210 into the delivery catheter 206, the vascular occlusion device 210 is pre-introduced into the sheath so that it is configured for delivery. Then, the distal end of the sheath is brought into contact with the proximal end 216 of the delivery catheter 206, and the vascular occlusion device 210 is pushed out of the sheath into the delivery catheter 206, thereby inserting the vascular occlusion device 210 into the delivery catheter 206, and thereby causing the vascular occlusion device 206 to remain in its delivery configuration within the delivery catheter 206.
[0061] In step 310, the occlusive device 210 is pushed distally from the delivery catheter 206 through the lumen 220 by pushing the proximal portion 250 of the pusher member 212. As the occlusive device 210 is pushed out from the open distal end 218 of the delivery catheter 206, the distal segment 230 advances through the aneurysm neck 248 into the aneurysm sac 240, thereby placing the occlusive device 210 inside the aneurysm sac 240. As the occlusive device 210 continues to advance out of the delivery catheter 206 via the pusher member 212, the main portion 224 also advances into the aneurysm sac 240. Once the occlusive device 210 is released from the delivery catheter 206, in step 312 the occlusive device 210 forms an unfolded configuration within the aneurysm sac 240. Once the entire vascular occlusion device 210 has been inserted into the aneurysm sac 240, step 314 detaches the vascular occlusion device 210 from the pusher member 212 by activating, activating, or otherwise manipulating the separation device 214. Step 316 removes the pusher member 212 from the patient's vascular system 242 by pulling it out via the delivery catheter 206. If a single vascular occlusion device 210 is sufficient to fill and occlude the aneurysm sac 240, method 300 proceeds to step 320 to remove the delivery catheter 206 from the patient's vascular system 242. With respect to steps 308-316, it is determined whether additional vascular occlusion devices 210 should be deployed. If multiple vascular occlusion devices 210 are to be implanted, the process of steps 308-318 is repeated to deliver a sufficient number of vascular occlusion devices 210 to fill and occlude the aneurysm sac 240. Once a sufficient number of vascular occlusion devices 210 have been implanted in the aneurysm sac 240, the delivery catheter 206 is removed in step 320.
[0062] While specific embodiments of the disclosed invention have been shown and described herein, it will be understood by those skilled in the art that they are not intended to limit the invention. Furthermore, it will be apparent to those skilled in the art that various changes and modifications (e.g., dimensions of various parts) can be made without departing from the scope of the disclosed invention as defined solely by the following claims and their equivalents. Therefore, the specification and drawings should be considered illustrative, not restrictive. The various embodiments of the disclosed invention shown and described herein are intended to cover alternatives, modifications, and equivalents of the disclosed invention that may fall within the appended claims.
Claims
1. It is a medical device, An elongated main portion having a proximal end and a distal end, comprising a main portion having a first bending rigidity, A non-traumatic distal segment, which is connected to the distal end of the main portion and extends distally from the distal end of the main portion, comprises a second non-traumatic distal segment having a second bending rigidity. A medical device characterized in that the ratio of the second bending stiffness to the first bending stiffness is within the range of 0.5 or more and 1.0 or less.
2. In the medical device described in claim 1, The main portion has a plurality of openings along the length direction of the main portion, A medical device characterized in that the non-traumatic distal segment has a distal tip, and the distal tip can enter the opening of the main portion and engage with the main portion.
3. In the medical device described in claim 1, A medical device characterized in that the ratio of the second bending stiffness to the first bending stiffness is within the range of 0.6 to 0.
8.
4. In a medical device according to any one of claims 1 to 3, A medical device characterized in that the elongated main portion includes one of the following: a braid, a mesh, and a tube having multiple openings.
5. In a medical device according to any one of claims 1 to 4, A medical device characterized in that the distal segment is one of a coil, a helical coil, a tube, a braid, and a flexible rod.
6. In a medical device according to any one of claims 1 to 5, A medical device characterized by further comprising a non-traumatic proximal portion that is coupled to the proximal end of a braided portion and extends proximal from the proximal end of the braided portion.
7. In a medical device according to any one of claims 1 to 6, A medical device characterized in that it is a vascular occlusion device.
8. A vascular occlusion device, An elongated braided portion comprising multiple elongated strands woven together, having a proximal end and a distal end, and having a first bending rigidity; A distal coil segment is connected to the distal end of the braided portion and extends distally from the distal end of the braided portion, and comprises a distal coil segment having a second bending rigidity. A vascular occlusion device characterized in that the ratio of the second bending stiffness to the first bending stiffness is within the range of 0.5 or more and 1.0 or less.
9. In the vascular occlusion device according to claim 8, The braided portion has a plurality of openings along the length direction of the braided portion, A vascular occlusion device characterized in that the distal coil segment has a distal tip, and the distal tip can enter the opening of the braided portion and engage with the main portion.
10. In the vascular occlusion device according to claim 8, A vascular occlusion device characterized by further comprising a proximal coil segment coupled to the proximal end of the braided portion and extending proximal from the proximal end of the braided portion.
11. In a vascular occlusion device according to any one of claims 8 to 10, A vascular occlusion device characterized in that the braided portion has a delivery configuration when it is confined within the delivery catheter and has an unfolded configuration when it is released from the delivery catheter.
12. In the vascular occlusion device according to claim 11, A vascular occlusion device characterized in that the delivery configuration is substantially linear in shape, and the unfolded configuration is three-dimensional in shape having a cross-sectional dimension at least three times that of the delivery configuration.
13. In a vascular occlusion device according to any one of claims 8 to 12, A vascular occlusion device characterized in that the braided portion is formed of a shape memory material.
14. In a vascular occlusion device according to any one of claims 8 to 13, A vascular occlusion device characterized in that the braided portion is formed from one of platinum, a platinum alloy, and a platinum-tungsten alloy.
15. In a vascular occlusion device according to any one of claims 8 to 13, A vascular occlusion device characterized in that the braided portion is formed from one of gold and a gold alloy.
16. In a vascular occlusion device according to any one of claims 8 to 13, A vascular occlusion device characterized in that the braided portion is formed from one of platinum-gold alloy and nitinol.
17. A method of using a vascular occlusion device according to any one of claims 8 to 15, The steps include advancing the delivery catheter within the patient's vascular system to the target anatomical cavity, The steps include inserting the vascular occlusion device into the proximal end of the delivery catheter and advancing the vascular occlusion device within the delivery catheter to the target anatomical cavity, A method characterized by comprising the step of advancing the vascular occlusion device from the delivery catheter into an anatomical cavity.
18. In the method according to claim 17, A method characterized in that the vascular occlusion device advances within the delivery catheter in a constrained delivery configuration, and when the vascular occlusion device advances into an anatomical cavity, it expands into a configuration different from the delivery configuration.
19. A vascular occlusion assembly, A vascular occlusion device according to any one of claims 8 to 16, A vascular occlusion assembly characterized by comprising a pusher member detachably coupled to the vascular occlusion device.
20. In the vascular occlusion assembly according to claim 19, A vascular occlusion assembly further comprising a separation device that detachably connects the pusher member to the vascular occlusion device.
21. In the vascular occlusion assembly according to claim 20, A vascular occlusion assembly characterized in that the separation device includes one of the following: electrolysis, mechanical connectors, and thermal melting.
22. A method of using a vascular occlusion assembly according to any one of claims 19 to 21, The steps include advancing the guidewire within the patient's vascular system to the target anatomical cavity, The steps include advancing the delivery catheter along the guidewire to the target anatomical cavity, The steps include inserting the vascular occlusion assembly into the delivery catheter and advancing the vascular occlusion device within the delivery catheter to the target anatomical cavity, A method characterized by comprising the step of pushing the vascular occlusion device from the delivery catheter into an anatomical cavity.
23. In the method of claim 22, The method further comprises the step of expanding the vascular occlusion device from a delivery configuration constrained within the delivery catheter to an expanded configuration different from the delivery configuration when the vascular occlusion device is pushed out of the delivery catheter into an anatomical cavity.
24. In the method according to claim 23, A method further comprising the step of activating the separation device in order to detach the vascular occlusion device from the pusher member.